$ANAC Anacor Pharmaceuticals, Inc. Insider Trading Week 49/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Anacor Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Anacor Pharmaceuticals, Inc. in week 49/2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | M | 5.54 | 3,000 | 16,620 | 0 | |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | M | 17.14 | 687 | 11,775 | 813 | |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | M | 7.55 | 1,500 | 11,325 | 0 | |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | M | 6.92 | 30,000 | 207,600 | 0 | |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | M | 6.74 | 15,000 | 101,100 | 0 | |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | M | 14.22 | 7,500 | 106,650 | 7,500 | |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | M | 5.20 | 12,500 | 65,000 | 0 | |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | M | 5.11 | 15,000 | 76,650 | 0 | |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | M | 0.60 | 834 | 500 | 0 | |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | M | 7.25 | 3,000 | 21,750 | 0 | |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Sell | S | 34.48 | 5,447 | 187,813 | 0 | 5.4 K to 0 (-100.00 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Sell | S | 34.45 | 44,384 | 1,528,873 | 28,000 | 72.4 K to 28 K (-61.32 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Sell | S | 34.92 | 120,032 | 4,191,878 | 72,384 | 192.4 K to 72.4 K (-62.38 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Sell | S | 34.91 | 30,801 | 1,075,183 | 5,447 | 36.2 K to 5.4 K (-84.97 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Sell | S | 35.79 | 3,000 | 107,359 | 36,248 | 39.2 K to 36.2 K (-7.64 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Buy | M | 5.54 | 3,000 | 16,620 | 39,248 | 36.2 K to 39.2 K (+8.28 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Sell | S | 35.79 | 687 | 24,585 | 36,248 | 36.9 K to 36.2 K (-1.86 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Buy | M | 17.14 | 687 | 11,775 | 36,935 | 36.2 K to 36.9 K (+1.90 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Sell | S | 35.79 | 1,500 | 53,680 | 36,248 | 37.7 K to 36.2 K (-3.97 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Buy | M | 7.55 | 1,500 | 11,325 | 37,748 | 36.2 K to 37.7 K (+4.14 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Sell | S | 35.79 | 30,000 | 1,073,592 | 36,248 | 66.2 K to 36.2 K (-45.28 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Buy | M | 6.92 | 30,000 | 207,600 | 66,248 | 36.2 K to 66.2 K (+82.76 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Sell | S | 35.79 | 15,000 | 536,796 | 36,248 | 51.2 K to 36.2 K (-29.27 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Buy | M | 6.74 | 15,000 | 101,100 | 51,248 | 36.2 K to 51.2 K (+41.38 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Sell | S | 35.79 | 7,500 | 268,398 | 36,248 | 43.7 K to 36.2 K (-17.14 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Buy | M | 14.22 | 7,500 | 106,650 | 43,748 | 36.2 K to 43.7 K (+20.69 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Sell | S | 35.79 | 12,500 | 447,330 | 36,248 | 48.7 K to 36.2 K (-25.64 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Buy | M | 5.20 | 12,500 | 65,000 | 48,748 | 36.2 K to 48.7 K (+34.48 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Sell | S | 35.79 | 15,000 | 536,796 | 36,248 | 51.2 K to 36.2 K (-29.27 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Buy | M | 5.11 | 15,000 | 76,650 | 51,248 | 36.2 K to 51.2 K (+41.38 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Sell | S | 35.79 | 834 | 29,846 | 36,248 | 37.1 K to 36.2 K (-2.25 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Buy | M | 0.60 | 834 | 500 | 37,082 | 36.2 K to 37.1 K (+2.30 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Sell | S | 35.79 | 3,000 | 107,359 | 36,248 | 39.2 K to 36.2 K (-7.64 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Buy | M | 7.25 | 3,000 | 21,750 | 39,248 | 36.2 K to 39.2 K (+8.28 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | M | 5.00 | 100 | 500 | 7,099 | |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Option Exercise | M | 5.00 | 4,800 | 24,000 | 7,199 | |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | S | 36.00 | 100 | 3,600 | 7,000 | 7.1 K to 7 K (-1.41 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Buy | M | 5.00 | 100 | 500 | 7,100 | 7 K to 7.1 K (+1.43 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Sell | S | 36.09 | 4,800 | 173,251 | 7,000 | 11.8 K to 7 K (-40.68 %) |
Dec 12 2014 | ANAC | Anacor Pharmaceuti ... | Zane Lee | SVP and Chief Medic ... | Buy | M | 5.00 | 4,800 | 24,000 | 11,800 | 7 K to 11.8 K (+68.57 %) |
Dec 10 2014 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Option Exercise | M | 5.59 | 40,104 | 224,181 | 14,896 | |
Dec 10 2014 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Option Exercise | M | 6.92 | 19,896 | 137,680 | 18,208 | |
Dec 10 2014 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Sell | S | 36.52 | 40,104 | 1,464,734 | 4,800 | 44.9 K to 4.8 K (-89.31 %) |
Dec 10 2014 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Buy | M | 5.59 | 40,104 | 224,181 | 44,904 | 4.8 K to 44.9 K (+835.50 %) |
Dec 10 2014 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Sell | S | 36.52 | 19,896 | 726,670 | 4,800 | 24.7 K to 4.8 K (-80.56 %) |
Dec 10 2014 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | SVP, Program Manage ... | Buy | M | 6.92 | 19,896 | 137,680 | 24,696 | 4.8 K to 24.7 K (+414.50 %) |